Advanced therapy medicinal products (ATMPs)

Advanced therapy medicinal products (ATMPs) according to 1394/2007 EC, are innovative, regenerative therapies which combine aspects of medicine, cell biology, science and engineering for the purpose of regenerating, repairing or replacing damaged tissues or cells’.

An ATMP is defined as either:

(a) a gene therapy ‘medicinal product’ ,
(b) a somatic cell therapy ‘medicinal product’ ,
(c) a tissue engineered product

Hematology/ Oncology

In Hematology/ Oncology the company is focused on active immunotherapy via autoloHematology/ Oncologygous dendritic cells for the treatment of orphan metastatic cancer diseases according to patient’s circulated tumour cells molecular signature

Neurology

In Neurology our focus is on supportive cellular therapies for the treatment of Chronic Spinal Cord Injury, Stroke, rare genetic CNS degenerative diseases ( Alzheimer s disease, Parkinson disease, MS ) and Autism.

Orthopedics/ General Surgery/ Dentistry

In Orthopedics/ General Surgery/ Dentistry the company is focused on standarised to growth factors-platelet enriched plasma procucts and bone marrow stem cells therapies for the treatment of osteoarthritis, bone/cartilage/muscle diseases and dental disorders

Cosmetics/ Plastic Surgery

In Cosmetics/ Plastic Surgery the company is focused on autologous cellular therapies for the skin rejuvenation in combination with autologous growth factors from peripheral blood and adipose tissue.

Hepatology

In Hepatology the company is focused on liver stem cells isolation and transplantation in patients suffered from Liver Failure.

Cardiology

In Cardiology the company is focused on autologous cardiac stem cells isolation, characterization and infusion in patients suffered from Chronic Heart Failure.

ONCO-DENDRIGENEATM

ONCO-DENDRIGENEATM

Dendritic cells- based active immunotherapy for the treatment of cancer solid tumors.

read more

NEUROGENEATM

NEUROGENEATM

For the treatment of spinal cord injuries, neurodegenerative diseases ( MS, Parkinson, Alzheimer ) , CNS injuries, Autism and cerebral pulsy.

read more

CARDIOGENEATM

CARDIOGENEATM

Mesenchymal stem cells derived Cardiopoietic Autologous Treatment for patients with Acute Myocardial Infarction.

read more

ARTHROGENEATM

ARTHROGENEATM

Autologous bone marrow mononuclear cells (aut. BM-MNCs) for the treatment of osteoarthritis (OA).

read more

PRPGENEATM

PRPGENEATM

Autologous platelet enriched plasma (PRP) in plastic surgery and cosmetics.

read more

LIVOGENEATM

LIVOGENEATM

Human heterologous hepatocytes transplantation in Hepatic Failure and other liver diseases.

read more